[1]

[2]

ZHAO Jingjing, ZHANG Peng, ZHOU Yong, CAO Yingping, HUANG Zhihu, FU Shengmiao, WANG Yuming, HONG Guolin, SHEN Jun, ZHENG Lei. A preliminary study on Lp-PLA2 and its relationship with LDL-C and hs-CRP in southern China [J]. Laboratory Medicine, 2021, 36(12): 1222-1228.

[3]

FAN Minghe, LIN Guangmin, HUANG Ruijie. TLR4 mRNA and HO-1 level in evaluating the condition and prognosis of ICVD [J]. Laboratory Medicine, 2021, 36(12): 1229-1233.

[4]

YI Qingqing, YANG Rong, LIANG Dongyu, CHANG Qing. Relationship between P53 expression and the recurrence,metastasis and prognosis of breast cancer patients [J]. Laboratory Medicine, 2019, 34(12): 1107-1110.

[5]

YI Qingqing, YANG Rong, LIANG Dongyu, CHANG Qing. Relationship between P53 expression and the recurrence,metastasis and prognosis of breast cancer patients [J]. Laboratory Medicine, 2019, 34(12): 1107-1110.

[6]

FANG Zixiang, ZHANG Xiao, CHEN Yan, WU Qi, ZHU Guoqing, LIU Ya, WANG Jiayi, SUN Fenyong, YU Lei. Role of TFCP2/YAP transcriptional complex co-regulated protein CPE for the diagnosis of hepatocellular carcinoma [J]. Laboratory Medicine, 2019, 34(2): 103-109.

[7]

FENG Ruijie, HU Xiaochen, ZHAO Lifang, ZHANG Haichen, SONG Yunxiao. Establishment on the reference intervals of serum lipoprotein-associated phospholipase A₂ in apparently healthy adults [J]. Laboratory Medicine, 2017, 32(6): 495-499.

[8]

GE Ping, XU Rong, CHEN Rong, WANG Jinghua, LIU Xuejie. Result analysis on quality control survey of bacterial vaginosis sialidase determination [J]. Laboratory Medicine, 2015, 30(11): 1083-1085.

[9]

[10]

. [J]. , 2014, 29(8): 862-864.

[11]

. [J]. , 2014, 29(3): 248-249.

[12]

[13]

[14]

[15]

. [J]. , 2013, 28(12): 1165-1166.

组别	年龄(岁)	例数	LAP(U/L)	95%CI(U/L)
对照组	22~46	898	16.83±5.48	11~22
早孕组	20~34	388	16.70±5.49	11~22
中孕组	21~36	315	26.05±5.99^*#	20~32
晚孕组	19~33	358	41.66±23.03^*#	18~64

组别	年龄(岁)	例数	LAP(U/L)	95%CI(U/L)
对照组	22~46	898	16.83±5.48	11~22
早孕组	20~34	388	16.70±5.49	11~22
中孕组	21~36	315	26.05±5.99^*#	20~32
晚孕组	19~33	358	41.66±23.03^*#	18~64

RichHTML

PDF (PC)

[1]	YAMAHARA N,NOMURA S,SUZUKI T,et al.Placental lencine aminopeptidase/oxytocinase in maternal serum and placenta during normal pregnancy[J]. Life Sci,2000,66(15): 1401-1410.
[2]	汤菲,张智慧,陈晶,等. 异常妊娠孕妇血清亮氨酸氨基肽酶活性检测的价值[J]. 检验医学,2014,29(8): 862-864.
[3]	NAKANISHI Y,NOMURA S,OKADA M,et al.Immunoaffinity purification and characterization of native placental leucine aminopeptidase/oxytocinase from human placenta[J]. Placenta,2000,21(7): 628-634.
[4]	NOMURA S,ITO T,YAMAMOTO E,et al.Gene regulation and physiological function of placental leucine aminopeptidase/oxytocinase during pregnancy[J]. Biochim Biophys Acta,2005,1751(1): 19-25.
[5]	KOZAKI H,ITAKURA A,OKAMURA M,et al.Maternal serum placental leucine aminopeptidase(P-LAP)/oxytocinase and preterm delivery[J]. Int J Gynaecol Obstet,2001,73(3): 207-213.